Share Facebook


05-21-2012, 11:05 AM   #1
Igor_Passau
Forum Monitor
 
Igor_Passau's Avatar
 
Join Date: Aug 2010
Location: Kyiv, Ukraine
Giaconda Limited (GIA)

Giaconda Limited (Giaconda) is a research focused biotechnology company, engaged in research, development and commercialization of innovative therapeutics for gastrointestinal diseases and disorders. The company focuses broadly on research and development activities in the area of digestive diseases. The pipeline products of the company includes Myoconda, Hepaconda, Heliconda and Ibaconda, and one bowel evacuant Picoconda. Myoconda is a combination antibiotic therapy being developed in Phase III clinical trial for the treatment of crohn's disease. Hepaconda is a combination of bezafibrate and chenodeoxycholic acid. It is in Phase Phase II clinical study for the treatment of hepatitis c virus. Its Heliconda and Picoconda are undergoing Phase III Clinical Trials for the treatment of Resistant Helicobacter pylori infection and Bowel Preparation for

http://reports.pr-inside.com/giacond...d-r3189911.htm
Reply

Thread Tools


All times are GMT -5. The time now is 11:59 AM.
Copyright 2006-2017 Crohnsforum.com